Kristin B. Schultes - Aug 21, 2025 Form 4 Insider Report for ACUREN CORP (TIC)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ MaryJo O'Brien, Attorney in Fact
Stock symbol
TIC
Transactions as of
Aug 21, 2025
Transactions value $
$0
Form type
4
Date filed
8/25/2025, 07:00 PM
Previous filing
Apr 15, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SCHULTES KRISTIN B CHIEF FINANCIAL OFFICER C/O ACUREN CORPORATION, 14434 MEDICAL COMPLEX DRIVE, SUITE 100, TOMBALL /s/ MaryJo O'Brien, Attorney in Fact 2025-08-25 0002046195

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TIC Performance Based Restricted Stock Units Award $0 +60K $0.00 60K Aug 21, 2025 Common Stock 60K Direct F3, F7
holding TIC Restricted Stock Units 30K Aug 21, 2025 Common Stock 30K Direct F1, F2
holding TIC Performance Based Restricted Stock Units 30K Aug 21, 2025 Common Stock 30K Direct F3, F4
holding TIC Restricted Stock Units 30K Aug 21, 2025 Common Stock 30K Direct F1, F5
holding TIC Performance Based Restricted Stock Units 60K Aug 21, 2025 Common Stock 60K Direct F3, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F2 These restricted stock units vest 33 1/3% on the first through third anniversaries of the grant date (December 3, 2024).
F3 Each performance based restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F4 These performance based restricted stock units shall vest, beginning on December 3, 2025, based on the Issuer's Common Stock achieving a specified volume-weighted average price per share over a 10-day period.
F5 These restricted stock units vest on the third anniversary of the grant date (April 11, 2025).
F6 These performance based restricted stock units have a three-year performance period and to the extent earned will vest on April 11, 2028. The number of shares of Common Stock that will be earned is subject to decrease based on the result of the performance condition.
F7 These performance based restricted stock units, to the extent earned, will vest on September 30, 2026. The number of shares of Common Stock that will be earned is subject to decrease based on the results of the performance condition.

Remarks:

Exhibit 24.1 - Power of Attorney